funding header

Funding Opportunities


Displaying 1 - 20 of 86

 

Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional)

RFA-CA-21-019
Application Receipt Date: June 9, 2021, November 18, 2021

Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)

RFA-CA-21-017
Application Receipt Date: June 8, 2021, November 17, 2021

Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)

RFA-CA-21-013
Application Receipt Date: June 8, 2021, November 17, 2021

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

RFA-CA-21-014
Application Receipt Date: June 8, 2021, November 17, 2021

Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

RFA-CA-21-015
Application Receipt Date: June 8, 2021, November 17, 2021

Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

RFA-CA-21-016
Application Receipt Date: June 8, 2021, November 17, 2021

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)

RFA-CA-21-003
Application Receipt Date: February 22, 2021, May 27, 2021, September 29, 2021

Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trial Not Allowed)

RFA-CA-21-005
Application Receipt Date: February 22, 2021, May 27, 2021, September 29, 2021

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

RFA-CA-21-006
Application Receipt Date: February 22, 2021, September 27, 2021, September 29, 2021

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

RFA-CA-21-004
Application Receipt Date: February 21, 2021, May 27, 2021, September 29, 2021

Collaborative Approaches to Engineer Biology for Cancer Applications (U01 Clinical Trial Not Allowed)

RFA-CA-20-054
Application Receipt Date: January 15, 2021

NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed)

PAR-20-287
Application Receipt Date: January 4, 2021

NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)

PAR-20-288
Application Receipt Date: January 4, 2021

Research Answers to NCI’s Provocative Questions (R01 Clinical Trial Optional)

RFA-CA-20-004
Application Receipt Date: June 2, 2020, November 17, 2020

Research Answers to NCI’s Provocative Questions (R21 Clinical Trial Optional)

RFA-CA-20-005
Application Receipt Date: June 2, 2020, November 17, 2020

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)

RFA-CA-20-018
Application Receipt Date: February 21, 2020, May 28, 2020, September 29, 2020

Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)

RFA-CA-20-019
Application Receipt Date: February 21, 2020, May 28, 2020, September 29, 2020

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)

RFA-CA-20-020
Application Receipt Date: February 21, 2020, May 28, 2020, September 29, 2020

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)

RFA-CA-20-017
Application Receipt Date: February 21, 2020, May 28, 2020, September 29, 2020

Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trials Optional)

RFA-CA-19-026
Application Receipt Date: March 7, 2019, May 28, 2019, September 27, 2019

Pages